Robles Abrianna S, Rockov Zachary A, Brien Earl W, Little Milton Thomas Michael
Department of Orthopaedic Surgery, Cedars Sinai Medical Center, Los Angeles, California.
J Orthop Case Rep. 2022 Nov;12(11):28-33. doi: 10.13107/jocr.2022.v12.i11.3402.
Phosphaturic mesenchymal tumor (PMT) is a rare benign tumor (500 cases to date) that can present in combination with a paraneoplastic syndrome called tumor-induced osteomalacia (TIO). To the best of our knowledge, it is the first case to date that presented as an orthopedic trauma patient.
This is a case of a 61-year-old male who initially presented as a polytrauma patient, but further investigation revealed a PMT causing TIO. This report describes his initial diagnosis and management from 2015 to 2021.
TIO resultant of PMT may lead to severe bone pain, impending fractures, and delayed or misdiagnosis. This case demonstrates the importance of careful diagnosis and a team-based approach to managing PMT and its sequelae.
磷酸尿性间叶肿瘤(PMT)是一种罕见的良性肿瘤(迄今为止有500例),可与一种称为肿瘤诱导性骨软化症(TIO)的副肿瘤综合征同时出现。据我们所知,这是迄今为止首例表现为骨科创伤患者的病例。
这是一名61岁男性的病例,他最初表现为多发伤患者,但进一步检查发现是PMT导致了TIO。本报告描述了他在2015年至2021年期间的初步诊断和治疗情况。
PMT导致的TIO可能会导致严重的骨痛、即将发生的骨折以及诊断延迟或误诊。本病例证明了仔细诊断以及采用基于团队的方法来管理PMT及其后遗症的重要性。